RMTI
ROCKWELL MEDICAL, INC.Company Information
- Company Name
- ROCKWELL MEDICAL, INC.
- CIK
- CIK0001041024
- Category
- Non-accelerated filer<br>Smaller reporting company
- Ticker: Exchange
- RMTI: Nasdaq
- Fiscal Year End
- December 31
- Owner Organization
- 03 Life Sciences
- SIC
- 2834
- SIC Description
- Pharmaceutical Preparations
- Ticker
- RMTI
SEC filing data through
Insider Sentiment
- Last purchase
- 2025-04-11
- Last sale
- 2026-01-02
- Shares purchased (TTM)
- 30,500
- Shares sold (TTM)
- 46,905
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 3,342,283
- Shares outstanding
- 3,958,568
- Ownership
- 84.43%
Earnings Market Reaction
- Filing date
- 2026-08-13
- Price on filing date
- —
- 1-month reaction
- 2.04%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 11 | 10 | 11 | 14 | 12 | 11 | 16 | 12 | 12 | 7 | 9 | 8 | ||||||
| Available For Sale Securities Debt Securities Current | - | - | 14 | - | - | - | 6 | 6 | 0 | 2 | 2 | 4 | ||||||
| Debt Securities Available For Sale Excluding Accrued Interest Current | 14 | 14 | - | 10 | 6 | 6 | - | - | - | - | - | - | ||||||
| Accounts Receivable Net Current | 8 | 9 | 8 | 8 | 8 | 10 | 8 | 9 | 11 | 11 | 11 | 9 | ||||||
| Inventory Net | 3 | 3 | 3 | 4 | 4 | 5 | 6 | 6 | 6 | 6 | 6 | 5 | ||||||
| Prepaid Expense And Other Assets Current | 0 | 1 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | ||||||
| Assets Current | 36 | 37 | 38 | 38 | 32 | 33 | 37 | 34 | 30 | 27 | 29 | 28 | ||||||
| Property Plant And Equipment Net | 5 | 4 | 5 | 5 | 5 | 5 | 6 | 6 | 6 | 6 | 6 | 7 | ||||||
| Inventory Noncurrent | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Operating Lease Right Of Use Asset | 4 | 5 | 3 | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 3 | 3 | ||||||
| Finance Lease Right Of Use Asset | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | ||||||
| Intangible Assets Net Excluding Goodwill | 9 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 11 | 11 | 11 | ||||||
| Goodwill | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Other Assets Noncurrent | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Assets | 57 | 57 | 57 | 57 | 53 | 54 | 59 | 57 | 53 | 51 | 52 | 53 | ||||||
Liabilities And Stockholders Equity | ||||||||||||||||||
| Accounts Payable Current | 3 | 3 | 2 | 2 | 2 | 2 | 3 | 3 | 3 | 5 | 5 | 4 | ||||||
| Accrued Liabilities Current | 4 | 3 | 4 | 4 | 4 | 5 | 6 | 6 | 6 | 5 | 7 | 7 | ||||||
| Asset Acquisition Contingent Consideration Liability Current | - | - | 1 | - | - | - | 2 | - | - | - | - | - | ||||||
| Business Combination Contingent Consideration Liability Current | 0 | 1 | - | 2 | 3 | 2 | 2 | 2 | 3 | 3 | 3 | 3 | ||||||
| Operating Lease Liability Current | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 1 | 1 | 1 | 2 | ||||||
| Finance Lease Liability Current | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Contract With Customer Liability Current | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Notes Payable | - | - | - | - | - | - | - | - | - | 0 | 0 | 0 | ||||||
| Long Term Debt Current | 2 | 1 | - | - | - | - | - | - | - | - | 0 | 6 | ||||||
| Short Term Bank Loans And Notes Payable | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | - | 0 | - | ||||||
| Contract With Customer Refund Liability Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Liabilities Current | 11 | 10 | 10 | 10 | 11 | 11 | 14 | 14 | 15 | 15 | 17 | 21 | ||||||
| Operating Lease Liability Noncurrent | 3 | 3 | 1 | 2 | 2 | 1 | 2 | 2 | 2 | 3 | 1 | 2 | ||||||
| Finance Lease Liability Noncurrent | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | ||||||
| Long Term Debt Noncurrent | 7 | 8 | 9 | 9 | 9 | 9 | 8 | 8 | 8 | 8 | 8 | 3 | ||||||
| Contract With Customer Liability Noncurrent | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Business Combination Contingent Consideration Liability Noncurrent | - | - | - | 0 | 0 | 1 | 1 | 2 | 3 | 3 | 3 | 3 | ||||||
| Asset Acquisition Contingent Consideration Liability Noncurrent | - | - | 0 | - | - | - | 1 | - | - | - | - | - | ||||||
| Other Liabilities Noncurrent | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Liabilities | 21 | 22 | 20 | 20 | 22 | 22 | 27 | 28 | 30 | 30 | 31 | 31 | ||||||
Stockholders Equity | ||||||||||||||||||
| Preferred Stock Value Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Value Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital | 441 | 440 | 440 | 439 | 431 | 431 | 430 | 426 | 422 | 420 | 418 | 417 | ||||||
| Retained Earnings Accumulated Deficit | -406 | -405 | -403 | -402 | -401 | -399 | -398 | -397 | -399 | -399 | -397 | -396 | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0 | 0 | -0 | 0 | ||||||
| Stockholders Equity | 35 | 36 | 37 | 37 | 30 | 32 | 33 | 29 | 23 | 21 | 21 | 22 | ||||||
| Liabilities And Stockholders Equity | 57 | 57 | 57 | 57 | 53 | 54 | 59 | 57 | 53 | 51 | 52 | 53 | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Allowance For Doubtful Accounts Receivable Current | - | - | - | - | - | - | 0 | - | - | - | 0 | - | ||||||
| Preferred Stock Shares Authorized | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | ||||||
| Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 170 | 170 | 170 | 170 | 170 | 170 | 170 | 170 | 170 | 170 | 170 | 170 | ||||||
| Common Stock Shares Issued | 4 | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | ||||||
| Shares Outstanding | 4 | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialROCKWELL MEDICAL, INC. (RMTI) — SEC Financial Statements & Analysis
ROCKWELL MEDICAL, INC. (RMTI) is a pharmaceutical preparations company, incorporated in DE. ROCKWELL MEDICAL, INC. trades on Nasdaq as: RMTI. ROCKWELL MEDICAL, INC. (RMTI)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-13. Based on that filing, ROCKWELL MEDICAL, INC. carries a market cap of $21.77M, a P/E ratio of -4.28x, a P/B ratio of 0.62x, a P/S ratio of 0.31x, an enterprise value of $20.70M, and an EV/EBITDA multiple of -8.52x. On profitability, it posts a gross margin of 17.71%, an operating margin of -6.52%, a net margin of -7.33%, a Return on Equity (ROE) of -15.53%, a Return on Assets (ROA) of -9.32%, and a Return on Invested Capital (ROIC) of -14.06%. Per share, it reports EPS of $-1.28, diluted EPS of $-1.28, free cash flow per share of $0.39, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of -21.12% year-over-year, net income growth of 142.21% year-over-year, and EPS growth of 109.94% year-over-year. On the balance sheet, it maintains a current ratio of 3.25x, a quick ratio of 2.96x, working capital of $25.19M, a debt-to-equity ratio of 0.61x, a debt ratio of 0.38, an interest coverage ratio of -3.99x, free cash flow of $1.54M (TTM), and net debt of $-1.07M. Figures sourced from SEC EDGAR.
- Market Cap
- $21.77M
- P/E TTM
- -4.28x
- EPS TTM
- $-1.28
- P/B TTM
- 0.62x
- ROE TTM
- -15.53%
- ROA TTM
- -9.32%
- Debt To Equity
- 0.61x
- Free Cash Flow TTM
- $1.54M
- Net Revenue TTM Growth 1Y
- -21.12%
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is ROCKWELL MEDICAL, INC. in?
ROCKWELL MEDICAL, INC. (RMTI) operates in the Pharmaceutical Preparations industry.
What exchange does RMTI trade on?
ROCKWELL MEDICAL, INC. (RMTI) trades on the Nasdaq.
Where is ROCKWELL MEDICAL, INC. incorporated?
ROCKWELL MEDICAL, INC. is incorporated in DE.
When was ROCKWELL MEDICAL, INC. (RMTI)'s most recent SEC filing?
ROCKWELL MEDICAL, INC. (RMTI)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-13.
What is RMTI's market cap?
ROCKWELL MEDICAL, INC. (RMTI) has a market capitalization of $21.77M as of 2026-06-30.
What is RMTI's EPS (earnings per share)?
ROCKWELL MEDICAL, INC. (RMTI)'s trailing twelve month EPS is $-1.28 as of 2026-06-30.
What is RMTI's ROE (return on equity)?
ROCKWELL MEDICAL, INC. (RMTI)'s trailing twelve month Return on Equity (ROE) is -15.53% as of 2026-06-30.
What is RMTI's ROA (return on assets)?
ROCKWELL MEDICAL, INC. (RMTI)'s trailing twelve month Return on Assets (ROA) is -9.32% as of 2026-06-30.
What is RMTI's ROIC (return on invested capital)?
ROCKWELL MEDICAL, INC. (RMTI)'s trailing twelve month Return on Invested Capital (ROIC) is -14.06% as of 2026-06-30.
What is RMTI's EV/EBITDA?
ROCKWELL MEDICAL, INC. (RMTI)'s trailing twelve month EV/EBITDA is -8.52x as of 2026-06-30.